Literature DB >> 30233732

Dysregulated ICOS+ proinflammatory and suppressive regulatory T cells in patients with rheumatoid arthritis.

Hong-Xia Wang1, Xia Kang1,2, Shuai Chu1, Haixia Li1, Xin Li1, Xiaofeng Yin1, Yu-Rong Qiu1, Weinan Lai3,4.   

Abstract

Regulatory T cells (Tregs) serve an important role in the pathogenesis of rheumatoid arthritis (RA) by regulating autoimmunity and inflammation. Humans and mice contain inducible T-cell costimulator-positive (ICOS+) Tregs, although their role in RA is unclear. A total of 33 patients with RA and 17 normal control (NC) subjects were examined. The proportion of ICOS+ Tregs in the peripheral blood and intracellular cytokine levels in these cells were assessed using flow cytometry. The percentage of ICOS+ Tregs increased in the cohort of patients with RA compared with the NCs. Such increases were much larger in patients with inactive RA compared with patients with active RA. Additionally, ICOS+ Tregs expressed multiple suppressive cytokines, including interleukin (IL)-10, transforming growth factor-β and IL-35, but expressed low levels of IL-17. Importantly, the expression of suppressive cytokines in ICOS+ Tregs from patients with active RA decreased, but IL-17 expression noticeably increased compared with patients with inactive RA. The present findings suggested that ICOS+ Tregs may perform inflammatory and inhibitory functions, and abnormal ICOS+ Tregs numbers and functions may contribute to the pathogenesis of RA.

Entities:  

Keywords:  cytokines; inducible T-cell costimulator-positive regulatory T cells; rheumatoid arthritis

Year:  2018        PMID: 30233732      PMCID: PMC6143914          DOI: 10.3892/etm.2018.6657

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

2.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

3.  Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

Authors:  Israel Gotsman; Nir Grabie; Rajat Gupta; Rosa Dacosta; Malcolm MacConmara; James Lederer; Galina Sukhova; Joseph L Witztum; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circulation       Date:  2006-10-23       Impact factor: 29.690

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 5.  Treg cells in rheumatoid arthritis: an update.

Authors:  Faye A H Cooles; John D Isaacs; Amy E Anderson
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

6.  The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis.

Authors:  Wenhong Wang; Shihe Shao; Zhijun Jiao; Mingquan Guo; Huaxi Xu; Shengjun Wang
Journal:  Rheumatol Int       Date:  2011-01-11       Impact factor: 2.631

7.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors:  Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

8.  [Functional status of T helper cells in rheumatoid arthritis and effect of etanercept].

Authors:  Ting-ting Lu; Ping Zhu; Xiao-yan Li; Chun-mei Fan
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2008-05

Review 9.  Control of Regulatory T Cell Migration, Function, and Homeostasis.

Authors:  Daniel J Campbell
Journal:  J Immunol       Date:  2015-09-15       Impact factor: 5.422

Review 10.  Th17 cells in immunity and autoimmunity.

Authors:  Simone Kennedy Bedoya; Brandon Lam; Kenneth Lau; Joseph Larkin
Journal:  Clin Dev Immunol       Date:  2013-12-26
View more
  1 in total

Review 1.  The advances of methotrexate resistance in rheumatoid arthritis.

Authors:  Jun Yu; Peng Zhou
Journal:  Inflammopharmacology       Date:  2020-08-05       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.